Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger L Nation

Showing results (221-230 of 247) with videos related to

Pageof 25
Sort By:
The Journal of Antimicrobial Chemotherapy|May 30, 2015
Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicolNusaibah Abdul Rahim, Soon-Ee Cheah, Matthew D Johnson, et al.
The Lancet. Microbe|July 1, 2022
Research priorities towards precision antibiotic therapy to improve patient careZackery P Bulman, Sebastian G Wicha, Elisabet I Nielsen, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2023
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment AnalysisGuohua An, C Buddy Creech, Nan Wu, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2018
Optimization of a Meropenem-Tobramycin Combination Dosage Regimen against Hypermutable and Nonhypermutable Pseudomonas aeruginosa via Mechanism-Based Modeling and the Hollow-Fiber Infection ModelCornelia B Landersdorfer, Vanessa E Rees, Rajbharan Yadav, et al.
The Journal of Antimicrobial Chemotherapy|April 18, 2023
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patientsGuohua An, C Buddy Creech, Nan Wu, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2023
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and HeteroresistanceJessica R Tait, Marina Harper, Sara Cortés-Lara, et al.
European Journal of Medicinal Chemistry|October 14, 2018
Norbornane-based cationic antimicrobial peptidomimetics targeting the bacterial membraneShane M Hickey, Trent D Ashton, Gareth Boer, et al.
Organic & Biomolecular Chemistry|May 12, 2015
Synthesis and evaluation of cationic norbornanes as peptidomimetic antibacterial agentsShane M Hickey, Trent D Ashton, Simren K Khosa, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 23, 2021
Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patientsPatrick O Hanafin, Roger L Nation, Marc H Scheetz, et al.
Analytical Chemistry|January 2, 2015
Significant accumulation of polymyxin in single renal tubular cells: a medicinal chemistry and triple correlative microscopy approachMohammad A K Azad, Kade D Roberts, Heidi H Yu, et al.
Pageof 25

Showing results (221-230 of 247) with videos related to

Sort By:
Pageof 25
The Journal of Antimicrobial Chemotherapy|May 30, 2015
Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicolNusaibah Abdul Rahim, Soon-Ee Cheah, Matthew D Johnson, et al.
The Lancet. Microbe|July 1, 2022
Research priorities towards precision antibiotic therapy to improve patient careZackery P Bulman, Sebastian G Wicha, Elisabet I Nielsen, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2023
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment AnalysisGuohua An, C Buddy Creech, Nan Wu, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2018
Optimization of a Meropenem-Tobramycin Combination Dosage Regimen against Hypermutable and Nonhypermutable Pseudomonas aeruginosa via Mechanism-Based Modeling and the Hollow-Fiber Infection ModelCornelia B Landersdorfer, Vanessa E Rees, Rajbharan Yadav, et al.
The Journal of Antimicrobial Chemotherapy|April 18, 2023
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patientsGuohua An, C Buddy Creech, Nan Wu, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2023
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and HeteroresistanceJessica R Tait, Marina Harper, Sara Cortés-Lara, et al.
European Journal of Medicinal Chemistry|October 14, 2018
Norbornane-based cationic antimicrobial peptidomimetics targeting the bacterial membraneShane M Hickey, Trent D Ashton, Gareth Boer, et al.
Organic & Biomolecular Chemistry|May 12, 2015
Synthesis and evaluation of cationic norbornanes as peptidomimetic antibacterial agentsShane M Hickey, Trent D Ashton, Simren K Khosa, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 23, 2021
Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patientsPatrick O Hanafin, Roger L Nation, Marc H Scheetz, et al.
Analytical Chemistry|January 2, 2015
Significant accumulation of polymyxin in single renal tubular cells: a medicinal chemistry and triple correlative microscopy approachMohammad A K Azad, Kade D Roberts, Heidi H Yu, et al.
Pageof 25